Seroprotection rate, mean fold increase, seroconversion rate: Which parameter adequately expresses seroresponse to influenza vaccination?

Virus Research

Volumn 103, Issue 1-2, 2004, Pages 125-132

  Beyer, W E P ^a   Palache, A M ^a,b   Luchters G ^c   Nauta, J ^b   Osterhaus, A D M E ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b Solvay Pharmaceuticals Inc   (Netherlands)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Antibody response; Data analysis; Inactivated; Influenza; Statistics; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ANTIBODY RESPONSE; CONFERENCE PAPER; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; LINEAR REGRESSION ANALYSIS; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; SEROCONVERSION; SEROLOGY;

ADULT; ANTIBODIES, VIRAL; HUMANS; IMMUNIZATION; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINES, INACTIVATED;

EID: 2442585128     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2004.02.024     Document Type: Conference Paper

References (16)

1. Beyer W.E.P., De Bruijn I.A., Palache A.M., Westendorp R.G.J., Osterhaus A.D.M.E. Protection against influenza after annually repeated vaccination. A meta-analysis of serological and field studies. Arch. Intern. Med. 159:1999;182-188
2. Beyer W.E.P., Palache A.M., Baljet M., Masurel N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine. 7:1989;385-394
3. Beyer W.E.P., Palache A.M., De Jong J.C., Osterhaus A.D.M.E. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine. 20:2002;1340-1353
4. Beyer W.E.P., Palache A.M., Osterhaus A.D.M.E. Comparison of serology and reactogenicity between influenza subunit vaccines and whole or split vaccines. A review and meta-analysis of the literature. Clin. Drug Invest. 15:1998;1-12
5. Beyer W.E.P., Palache A.M., Sprenger M.J.W., Hendriksen E., Tukker J.J., Darioli R., Van Der Water G., Masurel N., Osterhaus A.D.M.E. Effects of repeated annual influenza vaccination sero-response in young and elderly adults. Vaccine. 14:1996;1331-1339
6. Committee for Proprietary Medicinal Products (CPMP), 1992. The rules governing medicinal products in the European Community, vol. III, Addendum no. 2. Guidelines on the quality, safety and efficacy of medical products for human use. D. Clinical trials related to yearly licensing of influenza vaccine. pp. 93-99.
7. Committee for Proprietary Medicinal Products (CPMP), 1997. Note for Guidance on Harmonisation of Requirements for Influenza Vaccines (CPMP/BWP/214/96, dated 12 March 1997), pp. 15-19.
8. Dawson-Saunders, B., Trapp, R.G, 1990. Basic and Clinical Biostatistics. Appleton & Lange, East Norwalk, Connecticut, USA, p. 173.
9. De Jong J.C., Palache A.M., Beyer W.E.P., Rimmelzwaan G.F., Boon A.C.M., Osterhaus A.D.M.E. Haemagglutination-inhibiting antibody to influenza virus. Developments in Biologicals. 115:2003;63-73
10. Egger M.J., Coleman M.L., Ward J.R., Reading J.C., Williams H.J. Uses and abuses of analysis of covariance in clinical trials. Contr. Clin. Trials. 6:1985;12-24
11. Kaiser L. Adjusting for baseline: change or percentage change? Stat. Med. 8:1989;1183-1190
12. Palache, A.M., 1991. Influenza vaccination: the effect of dose and age on the antibody response. A methodological evaluation of serological vaccination studies. Dose-comparative serological studies: critical evaluation of the parameters to assess the antibody response to influenza vaccination. PhD thesis, Erasmus University, Rotterdam, The Netherlands, pp. 81-119 (Chapter 4).
13. Palache A.M., Beyer W.E.P., Lüchters G., Völker R., Sprenger M.J.W., Masurel N. Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature. Vaccine. 11:1993;892-908
14. Palache A.M., Scheepers H.S.J., De Regt V., Van Ewijk P., Baljet M., Brands R., Van Scharrenburg G.J.M. Safety, reactogenicity and immunogenicity of Mardin Darby Canine kidney cell-derived inactivated influenza subunit vaccine. A meta-analysis of clinical studies. Dev. Biol. Stand. 98:1999;115-125
15. Palmer, D.F., Dowdle, W.R., Coleman, M.T., Schild, G.C., 1975. Haemagglutination-inhibition test. In: Advanced laboratory techniques for influenza diagnosis. Procedural guide. US Dept. Hlth. Ed. Welfare, Atlanta, pp. 25-62.
16. Voth D.W., Feldman H.A., Steinschneider A. Comparative responses of elderly persons to aqueous and depot influenza vaccines. Arch. Environ. Hlth. 13:1966;576-585